The Novel Peptide Chm-273s Has Therapeutic Potential for Metabolic Disorders: Evidence from In Vitro Studies and High-Sucrose Diet and High-Fat Diet Rodent Models

The aim of this study was to develop a novel peptide potentially applicable for the treatment of metabolic conditions, such as obesity and type 2 diabetes (T2D). We identified CHM-273S from the list of peptides from milk hydrolysate obtained by HPLC/MS-MS. In vitro analysis of primary murine fibrobl...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitkin, Nikita A., Pavshintcev, Vsevolod V., Sukhanova, Iuliia A., Doronin, Igor I., Babkin, Gennady A., Sadagurski, Marianna, Malyshev, Anton V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611607/
https://www.ncbi.nlm.nih.gov/pubmed/36297523
http://dx.doi.org/10.3390/pharmaceutics14102088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9611607/
https://www.ncbi.nlm.nih.gov/pubmed/36297523
http://dx.doi.org/10.3390/pharmaceutics14102088

Ejemplares similares